ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/02/22 | 3,580 | 3,700 | 3,405 | 3,485 | -130 | -3.6% | 2,212,300 |
| 2024/02/21 | 3,715 | 3,745 | 3,575 | 3,615 | -140 | -3.7% | 1,546,300 |
| 2024/02/20 | 3,725 | 3,865 | 3,655 | 3,755 | +10 | +0.3% | 2,270,600 |
| 2024/02/19 | 3,630 | 3,830 | 3,605 | 3,745 | +145 | +4% | 3,254,500 |
| 2024/02/16 | 3,105 | 3,630 | 3,105 | 3,600 | +565 | +18.6% | 4,906,000 |
| 2024/02/15 | 3,035 | 3,035 | 2,986 | 3,035 | +500 | +19.7% | 1,520,500 |
| 2024/02/14 | 2,565 | 2,572 | 2,506 | 2,535 | -48 | -1.9% | 1,037,400 |
| 2024/02/13 | 2,557 | 2,613 | 2,517 | 2,583 | +34 | +1.3% | 1,147,100 |
| 2024/02/09 | 2,520 | 2,572 | 2,504 | 2,549 | +29 | +1.2% | 762,700 |
| 2024/02/08 | 2,459 | 2,550 | 2,459 | 2,520 | +99 | +4.1% | 1,483,700 |
| 2024/02/07 | 2,595 | 2,598 | 2,328 | 2,421 | -214 | -8.1% | 3,028,900 |
| 2024/02/06 | 2,589 | 2,664 | 2,545 | 2,635 | +53 | +2.1% | 871,000 |
| 2024/02/05 | 2,532 | 2,593 | 2,528 | 2,582 | +24 | +0.9% | 631,600 |
| 2024/02/02 | 2,621 | 2,645 | 2,558 | 2,558 | -61 | -2.3% | 907,700 |
| 2024/02/01 | 2,638 | 2,661 | 2,594 | 2,619 | -42 | -1.6% | 627,900 |
| 2024/01/31 | 2,638 | 2,667 | 2,593 | 2,661 | +7 | +0.3% | 622,900 |
| 2024/01/30 | 2,650 | 2,693 | 2,634 | 2,654 | +25 | +1% | 692,600 |
| 2024/01/29 | 2,738 | 2,741 | 2,609 | 2,629 | -90 | -3.3% | 1,264,300 |
| 2024/01/26 | 2,721 | 2,779 | 2,680 | 2,719 | +7 | +0.3% | 1,269,500 |
| 2024/01/25 | 2,651 | 2,715 | 2,622 | 2,712 | +36 | +1.3% | 918,600 |
| 2024/01/24 | 2,701 | 2,701 | 2,645 | 2,676 | -40 | -1.5% | 984,500 |
| 2024/01/23 | 2,735 | 2,740 | 2,663 | 2,716 | -9 | -0.3% | 1,133,200 |
| 2024/01/22 | 2,784 | 2,784 | 2,661 | 2,725 | -45 | -1.6% | 1,455,800 |
| 2024/01/19 | 2,847 | 2,847 | 2,770 | 2,770 | -52 | -1.8% | 893,900 |
| 2024/01/18 | 2,846 | 2,848 | 2,768 | 2,822 | -48 | -1.7% | 1,058,700 |
| 2024/01/17 | 2,900 | 2,944 | 2,860 | 2,870 | -27 | -0.9% | 907,100 |
| 2024/01/16 | 2,946 | 2,964 | 2,884 | 2,897 | -33 | -1.1% | 788,300 |
| 2024/01/15 | 3,075 | 3,080 | 2,930 | 2,930 | -145 | -4.7% | 1,476,600 |
| 2024/01/12 | 3,090 | 3,095 | 3,010 | 3,075 | +15 | +0.5% | 858,500 |
| 2024/01/11 | 2,966 | 3,085 | 2,966 | 3,060 | +125 | +4.3% | 1,322,800 |
| 2024/01/10 | 2,938 | 2,954 | 2,888 | 2,935 | +7 | +0.2% | 924,100 |
| 2024/01/09 | 2,842 | 3,005 | 2,841 | 2,928 | +132 | +4.7% | 2,321,200 |
| 2024/01/05 | 2,859 | 2,875 | 2,785 | 2,796 | -63 | -2.2% | 875,700 |
| 2024/01/04 | 2,782 | 2,869 | 2,721 | 2,859 | +29 | +1% | 1,341,700 |
| 2023/12/29 | 2,829 | 2,897 | 2,818 | 2,830 | +1 | ±0% | 1,281,300 |
| 2023/12/28 | 2,799 | 2,830 | 2,756 | 2,829 | +51 | +1.8% | 1,492,000 |
| 2023/12/27 | 2,822 | 2,885 | 2,771 | 2,778 | -69 | -2.4% | 1,695,800 |
| 2023/12/26 | 2,852 | 2,907 | 2,820 | 2,847 | +12 | +0.4% | 1,130,700 |
| 2023/12/25 | 2,811 | 2,855 | 2,773 | 2,835 | +28 | +1% | 1,234,400 |
| 2023/12/22 | 2,874 | 2,896 | 2,788 | 2,807 | -43 | -1.5% | 1,563,600 |
| 2023/12/21 | 2,900 | 2,960 | 2,850 | 2,850 | -33 | -1.1% | 1,967,900 |
| 2023/12/20 | 2,894 | 2,939 | 2,827 | 2,883 | +19 | +0.7% | 1,458,600 |
| 2023/12/19 | 2,825 | 2,941 | 2,800 | 2,864 | +38 | +1.3% | 2,519,000 |
| 2023/12/18 | 3,020 | 3,020 | 2,812 | 2,826 | -154 | -5.2% | 2,453,200 |
| 2023/12/15 | 3,050 | 3,095 | 2,971 | 2,980 | -70 | -2.3% | 1,327,000 |
| 2023/12/14 | 3,115 | 3,160 | 2,988 | 3,050 | +5 | +0.2% | 1,449,200 |
| 2023/12/13 | 3,060 | 3,120 | 3,010 | 3,045 | ±0 | ±0% | 875,100 |
| 2023/12/12 | 3,065 | 3,090 | 2,951 | 3,045 | -10 | -0.3% | 1,634,700 |
| 2023/12/11 | 3,160 | 3,210 | 3,055 | 3,055 | -90 | -2.9% | 1,450,000 |
| 2023/12/08 | 3,000 | 3,195 | 2,990 | 3,145 | +90 | +2.9% | 2,021,500 |
51～
100
件表示中 / 3451件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 241,700円 | +52.1% | +23.3% | 0.00% | 17.08倍 | 3.56倍 |
|
創薬ベンチャー。米国で人工骨も。中国の特発性肺線維症薬で高シェア、米中に研究開発機能 |
| ネクセラファーマ | 155,800円 | +150.7% | - | 0.00% | 39.82倍 | 2.09倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 持田薬 | 322,000円 | -1.2% | -37.3% | 2.48% | 25.94倍 | 0.90倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | 182,900円 | +2.6% | +11.5% | 2.84% | 21.44倍 | 0.83倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 鳥居薬 | 407,000円 | +7.3% | +16.8% | 2.95% | 24.34倍 | 0.95倍 |
|
ＪＴ傘下。自社製品の腎・透析、アレルゲン等の開発強化。柱の抗ＨＩＶ薬の販売権喪失が直撃 |
市場注目の銘柄
チャート関連のコラム
